FLESHNER NEIL E. (Chief Medical Officer) sold 15.7% of their position (564.20K shares) of POINT BIOPHARMA GLOBAL INC. on the open market
Open‑market sale worth $4.24M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/26/2022ACC: 0001104659-22-065250
DirectorOfficer· Chief Medical Officer
Since Jun 2021
-564.20K
Net shares
Net seller
$4.24M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
564.20K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−564.20K
Price / share
$7.51
Trade value
$4.24M
% of position
15.7%
5/25/2022
3.59M→3.02M
Total
Net shares
−564.20K
Net value
-$4.24M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/25/2022 | S · Sale | −564.20K | $7.51 | $4.24M | 15.7% | 3.59M | 3.02M |
| Total | −564.20K | -$4.24M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned358.00
Common Stock
IndirectShares owned233.17K
Total
233.53K indirect233.53K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 358.00 | Indirect |
| Common Stock | 233.17K | Indirect |
| Total | 233.53K | 233.53K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported